SCHEMBL2409198

SCHEMBL2409198

CNC(=O)c1ccc(-n2cnc3cnc(N)nc32)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 3/20 0.52
▸ MAPT P10636 3/20 0.43
▸ CFTR P13569 1/20 0.42
▸ RIPK1 Q13546 1/20 0.41
▸ RIPK3 Q9Y572 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ RPS6KA3 P51812 1/20 0.41
▸ DYRK1A Q13627 1/20 0.40
▸ MKNK1 Q9BUB5 1/20 0.40
▸ MKNK2 Q9HBH9 1/20 0.40
▸ IRAK4 Q9NWZ3 2/20 0.39
▸ FGFR1 P11362 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ PIK3CD O00329 1/20 0.38
▸ PIK3CA P42336 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2410524 0.85 CFTR (0.47) HDAC6MAPTCFTRRIPK1RIPK3
SCHEMBL17802582 0.84 CFTR (0.54) HDAC6MAPTCFTRTP53RPS6KA3
SCHEMBL2408806 0.83 CYP1A2 (0.44) MAPTRIPK1RIPK3TP53RPS6KA3
SCHEMBL2410186 0.80 MAPT (0.42) HDAC6MAPTRIPK1RIPK3ALDH1A1
SCHEMBL2408774 0.79 HPGD (0.41) HDAC6MAPTALDH1A1HPGDHSD17B10
SCHEMBL4978113 0.78 XDH (0.48) HDAC6MAPTRPS6KA3FGFR1KDM4E
SCHEMBL2408339 0.78 RPS6KA3 (0.48) RPS6KA3ALDH1A1HPGDHSD17B10PIK3CA
SCHEMBL2408398 0.78 PTPN11 (0.41) MAPTRIPK1RIPK3TP53RPS6KA3
SCHEMBL2533237 0.75 MKNK1 (0.36) MAPTRIPK1RIPK3TP53RPS6KA3
SCHEMBL2533233 0.75 RIPK1 (0.37) MAPTRIPK1RIPK3TP53RPS6KA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011106168-A1 PURINE COMPOUNDS FOR TREATING AUTOIMMUNE AND DEMYELINATING DISEASES DCAM PHARMA INC (US) 2011-09-01 — — WO claimed
WO-2011106168-A1 PURINE COMPOUNDS FOR TREATING AUTOIMMUNE AND DEMYELINATING DISEASES DCAM PHARMA INC (US) 2011-09-01 — — WO disclosed
Send feedback